“The home-grown vaccine, branded Covifenz, is based on a technology that uses plants in its development process to produce non-infectious particles that mimic the virus. It also uses recombinant technology, involving the genetic sequence of a virus, which employs living plants as a host.
Looking for good news?
— Meanwhile in Canada (@MeanwhileinCana) February 24, 2022
Vaccine manufacturers usually grow live viruses on animal-derived cells, but Canadian company Medicago invented a new method using plant proteins. The world's first plant-based vaccine.
After extensive testing, it was approved for use today by Health Canada pic.twitter.com/XG7H6KJCEK
Canadian regulators said on Feb. 24 that Medicago’s two-dose vaccine is approved for adults aged 18 to 64.”
The shot was jointly developed by Medicago, a Quebec City-based biopharma company owned by Mitsubishi Chemical and Philip Morris International, and Glaxo, the British pharma giant.
The new plant-based jimmy dean breakfast sandwich has poisoned my body
— Weston (vaccine believer/bears fan) (@wessnoddy) February 28, 2022
The approval gives people who might be hesitant to take currently available vaccines made by Pfizer, AstraZeneca, Moderna and others another option.